Medicinal Cannabis

Tonia Antoniazzi Excerpts

Monday 18th June 2018 Commons Chamber

[Tonia Antoniazzi (Gower) (Lab)]

(Urgent Question): To ask the Home Secretary if he will make a statement on the granting of an emergency licence to allow the return of medical cannabis for Billy Caldwell.

[The Minister for Policing and the Fire Service (Mr Nick Hurd)]

Over the weekend, my right hon. Friend the Home Secretary issued an emergency licence to allow Billy Caldwell’s medical team to access cannabis-based medicine. This was an emergency procedure, led by a senior clinician with the support of the medical director at Chelsea and Westminster Hospital. I am sure that the whole House will want to join me in expressing genuine concern for Billy’s health, and that they will be pleased with the news that he has been discharged from hospital today.

The course of action in this case was unprecedented. I should explain that our guiding principle is that any process in this context must be clinically led and evidence based. To date, Home Office policy has been to permit the production, supply and possession of raw cannabis solely for research purposes under a Home Office licence. The cannabis-based medicine Sativex is currently the only one that can be prescribed in the UK, because there is a proven case for its safety and efficacy. However, this case and that of Alfie Dingley and others have shone a light on the use of cannabis-based medicine in this country and highlighted the need for the Government to explore the issue, and our handling of these issues, further.

I recognise the need to ensure that the approach to licensing works more effectively. As a first step, I can announce today that the Government are establishing an expert panel of clinicians to advise Ministers on any individual applications to prescribe cannabis-based medicines. This is consistent with the principle that a clinician must be at the heart of the process. I have asked Dame Sally Davies to take forward this important work. Let me be clear that both the Home Secretary and I have, as fathers, been profoundly moved by Billy’s story and others like it, along with the rest of the House and the rest of the country. I want to reassure the families and the public that the Home Secretary and I are working together to do all we can to take forward the necessary steps at pace, and that more announcements will be forthcoming.

[Tonia Antoniazzi]

I would like to thank the Minister for coming to the House today to discuss this urgent question. The Home Secretary has now conceded that cannabis has medicinal benefits by granting the emergency licence for Billy Caldwell on expert advice. When can we expect to see more import licences to make medicinal cannabis available to all who would benefit from it? Moreover, will the Government support the Bill introduced by my hon. Friend the Member for Newport West (Paul Flynn) on the legalisation of cannabis for medicinal purposes, when it returns on 6 July?

On 20 February, an urgent question was raised by the hon. Member for Reigate (Crispin Blunt) about Alfie Dingley’s case. Billy Caldwell is now in exactly the same situation. At that time, the Minister told the House that he would undertake

“to explore every option within the current regulatory framework.”—[Official Report, 20 February 2018; Vol. 636, c. 25.]

Now, 119 days later, the Government have still not granted Alfie Dingley his medicine. That medicine is available in 37 other countries. The Prime Minister met Alfie in Downing Street on 20 March and he was told that the Government would do all they could to help him. Billy Caldwell was hospitalised last week after his prescribed medical cannabis was taken away by customs officers, so it is excellent news that he left hospital today, but hon. Members will have been alarmed to hear the Health Secretary say this morning that it will be months before a system is in place to get medicinal cannabis to such children, and other patients who require it. Will the Minister give an assurance that Alfie Dingley will have had his medicine by the time he comes to Parliament with his mother on Wednesday?

Moreover, I also have two children in my constituency—the only two in Wales and two of just 15 in the United Kingdom—who have the rare genetic disorder NKH, which is a serious, life limiting condition. Charlie Jones, who is six, and Jace Newton-Sealey, who is just one, both suffer from frequent debilitating cluster seizures. According to their consultant neurologist, to whom I spoke earlier, both would benefit hugely from using medical cannabis. Charlie’s grandad, Ian Gilmore, has been in contact with the Home Office since 2014, when he learned of the benefits of cannabis for Charlie, but he has been given conflicting advice, pushed from pillar to post and fobbed off.

Will the Minister say when his Department will get a grip on the situation? Why the delay until now? Why is an announcement not being made today that this medicine will be available now to all who need it? Many patients—this is what I have a problem with—are illegally accessing cannabis, which opens them up to using the wrong form of the drug. The Government have a duty to protect patients and sufferers, so when will the Minister act? Why—

[Mr Speaker]

Order. I granted this question because it is urgent, but the hon. Lady has already exceeded her time by 50%. I assume that she is drawing towards a conclusion.

[Tonia Antoniazzi]

I will conclude right now. Why are the Government stuck in the dark ages? What will the Home Secretary do to speed up the process? In response to, “When?” the answers, “Next week,” “Next month,” or “In due course,” are simply not good enough.

[Mr Hurd]

I thank the hon. Lady for that long list of questions, and I will do my best to answer them. She asked about the recognition of the medical benefits of some cannabis-based medicine but, as I said in my response, they are already recognised by the fact that, for example, Sativex can be prescribed in the UK. Its safety and efficacy have been proven, and it has been rigorously tested. She will know the responsibility of the Government and everyone involved in the process to ensure that medicines are safe, but the system allows for medicines to be licensed once they are established and tested.

The hon. Lady mentioned the case of Alfie Dingley, with which I am familiar, and I made it clear that, however we may feel about the current rules, I undertook to try to find a solution for Alfie within the existing rules. Again, it is an unprecedented situation, because this is the first time that we are considering a personal licence, so this is new ground for everyone. I can confirm to her, as I confirmed to the family, that the process of applying for a licence to find a long-term sustainable legal solution for Alfie is well under way. It is clinically led, and I have given assurances that we will drive the process as hard as possible. Indeed, a date has been set for a compliance visit, which is a necessary part of the process. We are pushing things as hard as possible, and I want to place on the record my thanks, appreciation and respect for the dignity and patience of Alfie’s family in this difficult situation.

The hon. Lady challenges the Government to change fast, and I think I have made it clear that, as the Prime Minister said this morning, we have to look hard at our processes for handling such situations. We must ensure, as the Health Secretary made clear today, that our policy is fully up to date with the best possible understanding of the most recent and relevant evidence. As I am sure the hon. Lady will appreciate, the Government have to take a bit of time to think things through. We have to get the detail right. We do not have the luxury of opposition; we have to work through the detail to get this right. My statement recognises not only that we are taking immediate steps to improve our processes so that they become more clinically led, with the introduction of a new clinically-led panel of experts to advise Ministers, but that we are taking a wider look at policy processes and will be making a forthcoming announcement.

Vote 100 and International Women’s Day

Tonia Antoniazzi Excerpts

Thursday 8th March 2018 Commons Chamber

[Tonia Antoniazzi (Gower) (Lab)]

It is a pleasure to follow the hon. Member for Edinburgh North and Leith (Deidre Brock).

It is an honour to speak today in this extremely important debate on International Women’s Day. I hope to raise awareness in this House of the significant challenges that still face women in politics in this significant year celebrating 100 years since some women got the vote.

On arriving in Westminster last June, it was quite extraordinary how a group of us became friendly, having realised that we were all in very similar situations. Just one of the common denominators was that we were single parents, elected to Parliament; and the other was that we were women. At least five of us found ourselves thrust from being working single parents to Members of Parliament, practically overnight, but, every day, we are proud to be working-class women standing up for our communities.

I am very proud to be a member of the Women and Equalities Committee, and to be part of the all-party group on single parent families, which will be officially launched on International Single Parents Day on 21 March. In one of my very first conversations with the chair, my hon. Friend the Member for Ealing Central and Acton (Dr Huq), she said that she had never discussed being a single mother before. It seemed that, in our company, she felt comfortable enough to speak about it. Being a single parent is not a status that people necessarily want to share, as it brings with it a stigma. It would be interesting to know, across this House, how many Members are single parents. It is imperative that we stand together to recognise the challenges that lone parents face every day. In the media, Stacey Solomon has championed being a single mother and taken a lot of criticism for it, but she speaks plainly and openly about the “mummy guilt” that goes with working away from home and with being in the public eye.

There are many challenges that I have experienced since becoming an MP. Balancing family life is not easy. It can be impossible to maintain a relationship and, unfortunately, that is one of the sacrifices that I have had to make. Throughout my working life, I have seen at first hand how many women are juggling balls—I have always been proud of the fact that that is something that I can do, but I have always known that even the most talented jugglers drop a ball. When someone is on their own, when they are the provider, the organiser, the mother, the daughter, the person who people depend on, where do they turn when that ball drops? Sadly, many women return to abusive relationships, go further into debt, or turn to alcohol, drugs or anti-depressants.

A report by the Joseph Rowntree Foundation in July last year shows how single parents on low incomes are being hit so hard by rising living costs and the benefits freeze. How they cope with the impact of low pay and insecurity is of great concern to me and my colleagues, because, although we have been working in relatively well-paid jobs, we know at first hand that the cost of a divorce or separation is not only financial, but emotional. Only last night, when I should have been preparing this speech, I had chats with two friends who I studied A-levels with—unfortunately, not maths. They are both ambitious and talented women—we have shared a life journey—and both are happily married with three children. One battles daily in her place of work to have her hard work and dedication recognised, and she is too scared to ring her union because she fears a backlash and being seen as a troublemaker. That is not the sort of working environment that we want for women, or for anybody in society, in 2018.

I was telling my friend, in contrast, about our other friend, who lives in Melbourne, Australia. The friend I was speaking to said, “Please don’t tell me about her perfect beach life down under.” Unfortunately, I had to tell her that our friend suffered something similar to a stroke two months ago and has been told that even after intensive physiotherapy, a full recovery is unlikely. Regardless of that, I said to her, “I am sending you strength and love on International Women’s Day.” She told me that her 15-year-old daughter is doing a presentation today to 600 students in her middle school about inspiring women, and that she was going to talk about this famous woman—a teacher, a single mother and a family friend—who followed her dreams so that she could influence change.

On International Women’s Day, I can tell Members that women from all walks of life are fighting a daily battle and desperately trying to hold it together. It is great that the dynamics of this House are changing. Being a female Member of Parliament is incredible, and I am still, and always will be, full of awe and wonder at the privilege. Every woman faces a challenge every day, and the challenges that we face reflect the challenge that our society puts on women every day, from harassment in all its forms to putting food on the table and providing a home for our children.

We have many challenges in getting more women into politics, and we need to identify the barriers in order to make careers in politics more accessible to women. It is at the grassroots of politics that we need to look. I read in The Guardian yesterday that Sarah Childs from Birkbeck, University of London argues that political parties need to think again about how they assess women’s contributions. If long service is a condition of selection, for example, it automatically discriminates against women with caring responsibilities. She called for a rethink of what constitutes a good party member, because the way that is viewed often excludes women. It is well known that I am a latecomer to politics—a relative newbie in the party—and I am glad to say that in my short time in politics, my potential and talent have been recognised in my selection by Welsh Labour.

I often draw comparisons from my time playing rugby. Obviously, I believe that rugby is the best team sport in the world. Rugby union provides a platform for a wide range of players, and that, for me, is the key to a successful team. A successful political team has its forwards and its backs. It draws from a wide range of skills, but, more importantly, it represents society. We have to strive to be a political team that reflects our communities—50:50. The new Labour intake and the new intake across the House in 2017 have brought a new dynamic not just to the Labour party, but to this Parliament. I look forward to us continuing to make a difference to the lives of women in the United Kingdom and across the world.

Medical Cannabis

Tonia Antoniazzi Excerpts

Tuesday 20th February 2018 Commons Chamber

[Mr Hurd]

As I said in my statement, the UK has a view, which is that cannabis in its raw form is not recognised in the UK as having any medicinal benefits. As I also said, I recognise that there may be special circumstances in this case, which is why I am absolutely determined to look at every option inside the existing regulatory envelope.

[Tonia Antoniazzi (Gower) (Lab)]

As a Welsh MP, I am very proud of the Welsh Assembly, which recognises the need to legalise cannabis for medicinal use. Sativex is a very unpleasant, alcohol-based medicine that is unsuitable for many patients, and I hope that the Government will recognise that. However, we as a country are light years behind other countries, so the excuses today are just not valid. Why does the word “cannabis” scare the Government so much? We need to stop hiding and stop making excuses. Can the Minister tell the parents of children such as Alfie and all the other people who need access to medicinal cannabis legally across the UK when that is going to happen?

[Mr Hurd]

What the Government do is listen to the independent, statutory Advisory Council on the Misuse of Drugs, which has been very clear that

“the use of cannabis is a significant public health issue. Cannabis can unquestionably cause harm to individuals and society.”

We cannot just ignore that expert advice. As I said in my statement, there is a precedent for medicines, including controlled drugs such as cannabis and Sativex, to be issued with a licence to enable trials.